| Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH registry EM Degoma, ZS Ahmad, EC O’Brien, I Kindt, P Shrader, CB Newman, ... Circulation: Cardiovascular Genetics 9 (3), 240-249, 2016 | 206 | 2016 |
| Association of serial Kansas City Cardiomyopathy Questionnaire assessments with death and hospitalization in patients with heart failure with preserved and reduced ejection … Y Pokharel, Y Khariton, Y Tang, ME Nassif, PS Chan, SV Arnold, ... JAMA cardiology 2 (12), 1315-1321, 2017 | 146 | 2017 |
| Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year … B Brodie, Y Pokharel, N Fleishman, A Bensimhon, G Kissling, C Hansen, ... JACC: Cardiovascular Interventions 4 (1), 30-38, 2011 | 113 | 2011 |
| Genetics of familial hypercholesterolemia A Brautbar, E Leary, K Rasmussen, DP Wilson, RD Steiner, S Virani Current Atherosclerosis Reports 17, 1-17, 2015 | 103 | 2015 |
| Association of midlife lipids with 20-year cognitive change: a cohort study MC Power, A Rawlings, AR Sharrett, K Bandeen-Roche, J Coresh, ... Alzheimer's & Dementia 14 (2), 167-177, 2018 | 102 | 2018 |
| Adoption of the 2013 American College of Cardiology/American Heart Association cholesterol management guideline in cardiology practices nationwide Y Pokharel, F Tang, PG Jones, V Nambi, VA Bittner, RS Hira, K Nasir, ... JAMA cardiology 2 (4), 361-369, 2017 | 102 | 2017 |
| Provider understanding of the 2013 ACC/AHA cholesterol guideline SS Virani, Y Pokharel, L Steinberg, W Chan, JM Akeroyd, SA Gowani, ... Journal of clinical lipidology 10 (3), 497-504. e4, 2016 | 71 | 2016 |
| Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation … B Brodie, Y Pokharel, A Garg, G Kissling, C Hansen, S Milks, M Cooper, ... JACC: Cardiovascular Interventions 5 (10), 1043-1051, 2012 | 70 | 2012 |
| Statin use and its facility‐level variation in patients with diabetes: insight from the Veterans Affairs National Database Y Pokharel, JM Akeroyd, DJ Ramsey, RS Hira, V Nambi, T Shah, ... Clinical cardiology 39 (4), 185-191, 2016 | 54 | 2016 |
| Practice-level variation in statin use among patients with diabetes: insights from the PINNACLE registry Y Pokharel, K Gosch, V Nambi, PS Chan, M Kosiborod, WJ Oetgen, ... Journal of the American College of Cardiology 68 (12), 1368-1369, 2016 | 52 | 2016 |
| Postprandial monocyte activation in individuals with metabolic syndrome IM Khan, Y Pokharel, RT Dadu, DE Lewis, RC Hoogeveen, H Wu, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 4195-4204, 2016 | 50 | 2016 |
| Health system’s readiness to provide cardiovascular, diabetes and chronic respiratory disease related services in Nepal: analysis using 2015 health facility survey U Ghimire, N Shrestha, B Adhikari, S Mehata, Y Pokharel, SR Mishra BMC public health 20 (1), 1163, 2020 | 46 | 2020 |
| High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study Y Pokharel, W Sun, JA De Lemos, GE Taffet, SS Virani, CE Ndumele, ... Hypertension 65 (1), 78-84, 2015 | 46 | 2015 |
| Personalizing the intensity of blood pressure control: modeling the heterogeneity of risks and benefits from SPRINT (Systolic Blood Pressure Intervention Trial) KK Patel, SV Arnold, PS Chan, Y Tang, Y Pokharel, PG Jones, JA Spertus Circulation: Cardiovascular Quality and Outcomes 10 (4), e003624, 2017 | 45 | 2017 |
| Risk factor optimization and guideline-directed medical therapy in US veterans with peripheral arterial and ischemic cerebrovascular disease compared to veterans with coronary … RS Hira, JB Cowart, JM Akeroyd, DJ Ramsey, Y Pokharel, V Nambi, ... The American Journal of Cardiology 118 (8), 1144-1149, 2016 | 43 | 2016 |
| Association between social vulnerability index and cardiovascular disease: a behavioral risk factor surveillance system study V Jain, M Al Rifai, SU Khan, A Kalra, F Rodriguez, Z Samad, Y Pokharel, ... Journal of the American Heart Association 11 (15), e024414, 2022 | 38 | 2022 |
| The association of lipoprotein (a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study A Agarwala, Y Pokharel, A Saeed, W Sun, SS Virani, V Nambi, ... Atherosclerosis 262, 131-137, 2017 | 38 | 2017 |
| Bleeding complications in lower-extremity peripheral vascular interventions: insights from the NCDR PVI registry B Bhardwaj, JA Spertus, KF Kennedy, WS Jones, D Safley, TT Tsai, ... JACC: Cardiovascular Interventions 12 (12), 1140-1149, 2019 | 34 | 2019 |
| Myocardial injury, obesity, and the obesity paradox: the ARIC study Y Pokharel, W Sun, SS Virani, V Nambi, RC Hoogeveen, PP Chang, ... JACC: Heart Failure 5 (1), 56-63, 2017 | 30 | 2017 |
| Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study Y Pokharel, W Sun, LM Polfus, AR Folsom, G Heiss, AR Sharrett, ... Atherosclerosis 241 (2), 641-648, 2015 | 29 | 2015 |
